Kolon Life Revenue vs. Price To Sales

102940 Stock  KRW 19,630  370.00  1.85%   
Based on the measurements of profitability obtained from Kolon Life's financial statements, Kolon Life Science may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in January. Profitability indicators assess Kolon Life's ability to earn profits and add value for shareholders.
For Kolon Life profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Kolon Life to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Kolon Life Science utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Kolon Life's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Kolon Life Science over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Kolon Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if Kolon Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kolon Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Kolon Life Science Price To Sales vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Kolon Life's current stock value. Our valuation model uses many indicators to compare Kolon Life value to that of its competitors to determine the firm's financial worth.
Kolon Life Science is the top company in revenue category among its peers. It also is number one stock in price to sales category among its peers . The ratio of Revenue to Price To Sales for Kolon Life Science is about  49,781,995,776 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Kolon Life by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Kolon Life's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Kolon Revenue vs. Competition

Kolon Life Science is the top company in revenue category among its peers. Market size based on revenue of Pharmaceuticals industry is presently estimated at about 2.14 Trillion. Kolon Life holds roughly 165.49 Billion in revenue claiming about 8% of equities listed under Pharmaceuticals industry.

Kolon Price To Sales vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Kolon Life

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
165.49 B
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.

Kolon Life

P/S

 = 

MV Per Share

Revenue Per Share

 = 
3.32 X
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.

Kolon Price To Sales Comparison

Kolon Life is currently under evaluation in price to sales category among its peers.

Kolon Life Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Kolon Life, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Kolon Life will eventually generate negative long term returns. The profitability progress is the general direction of Kolon Life's change in net profit over the period of time. It can combine multiple indicators of Kolon Life, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Kolon Life Science Inc. provides biopharmaceuticals, active pharmaceutical ingredients, antimicrobials, and water solutions primarily in South Korea. Kolon Life Science Inc. was founded in 2000 and is headquartered in Gwacheon, South Korea. Kolon Life is traded on Korean Securities Dealers Automated Quotations in South Korea.

Kolon Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Kolon Life. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Kolon Life position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Kolon Life's important profitability drivers and their relationship over time.

Use Kolon Life in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Kolon Life position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kolon Life will appreciate offsetting losses from the drop in the long position's value.

Kolon Life Pair Trading

Kolon Life Science Pair Trading Analysis

The ability to find closely correlated positions to Kolon Life could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Kolon Life when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Kolon Life - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Kolon Life Science to buy it.
The correlation of Kolon Life is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Kolon Life moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Kolon Life Science moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Kolon Life can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Kolon Life position

In addition to having Kolon Life in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Chemicals Thematic Idea Now

Chemicals
Chemicals Theme
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Chemicals theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Chemicals Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Kolon Stock

To fully project Kolon Life's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Kolon Life Science at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Kolon Life's income statement, its balance sheet, and the statement of cash flows.
Potential Kolon Life investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Kolon Life investors may work on each financial statement separately, they are all related. The changes in Kolon Life's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Kolon Life's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.